5α-Reductase inhibitor

Dutasteride

5α-Reductase inhibitors (5-ARIs), also known as dihydrotestosterone (DHT) blockers, are a class of medications that prevent the conversion of testosterone into dihydrotestosterone (DHT) by inhibiting the action of the enzyme 5α-reductase. DHT is a hormone that plays a significant role in the development of certain androgen-related conditions such as benign prostatic hyperplasia (BPH), prostate cancer, and pattern hair loss.

Mechanism of Action

5α-Reductase inhibitors work by blocking the activity of the enzyme 5α-reductase. This enzyme is responsible for the conversion of testosterone, a major male sex hormone, into dihydrotestosterone (DHT) in certain tissues of the body including the prostate gland, skin, and hair follicles. By inhibiting this conversion, 5-ARIs reduce the levels of DHT, leading to a decrease in the symptoms associated with its excess.

There are two main types of 5α-reductase, type I and type II, with differing distributions throughout the body. Most 5-ARIs are selective for the type II enzyme, which is primarily found in the prostate gland. However, drugs that inhibit both types of the enzyme are also available and may be used in the treatment of conditions like pattern hair loss, where both types of the enzyme are involved.

Clinical Uses

5α-Reductase inhibitors are primarily used in the treatment of:

• Benign Prostatic Hyperplasia (BPH) - They reduce the size of the prostate gland and alleviate symptoms such as difficulty in urinating.
• Prostate Cancer - Although not a first-line treatment, they may be used in certain cases to slow the progression of the disease.
• Pattern Hair Loss (Androgenetic Alopecia) - By reducing DHT levels, they can slow hair loss and in some cases, promote hair regrowth.

Side Effects

While 5α-reductase inhibitors are generally well-tolerated, they can have side effects, including:

• Sexual dysfunction (e.g., decreased libido, erectile dysfunction)
• Gynecomastia (enlargement of breast tissue in men)
• Depression
• Increased risk of high-grade prostate cancer with long-term use

Patients are advised to discuss the potential risks and benefits of 5-ARIs with their healthcare provider.

Available Medications

Some of the commonly prescribed 5α-reductase inhibitors include:

• Finasteride - Primarily used for BPH and pattern hair loss.
• Dutasteride - Used for BPH and, in some countries, for pattern hair loss.

Conclusion

5α-Reductase inhibitors represent an important class of medications in the management of conditions related to the effects of dihydrotestosterone. By understanding their mechanism of action, clinical uses, and potential side effects, healthcare providers can better guide their patients in making informed treatment decisions.

‎